ArticleThe Journal of allergy and clinical immunology2023

Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells.

Doumet Georges Helou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.